Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Walz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Pediatrics|December 23, 2022
Evidence Suggests a Decrease in the Incidence of Kernicterus in CaliforniaLucas Walz, Jordan C Brooks, Thomas Newman
Developmental Medicine and Child Neurology|April 10, 2023
Severe cerebral palsy survival is similar in California, USA and Victoria, AustraliaLucas Walz, Jordan C Brooks, David J Strauss, et al.
Multiple Sclerosis and Related Disorders|October 16, 2022
Life expectancy in multiple sclerosis by EDSS scoreLucas Walz, Jordan C Brooks, Robert M Shavelle, et al.
Breast Cancer Research and Treatment|August 26, 2020
Increasing accrual of minority patients in breast cancer clinical trialsAmelia A Trant, Lucas Walz, Whitney Allen, et al.
Plos One|November 23, 2021
Knowledge of and preparedness for COVID-19 among Somali healthcare professionals: A cross-sectional studyJude Alawa, Lucas Walz, Samir Al-Ali, et al.
BMJ Open|June 30, 2021
Knowledge and perceptions of COVID-19, prevalence of pre-existing conditions and access to essential resources in Somali IDP camps: a cross-sectional studyJude Alawa, Samir Al-Ali, Lucas Walz, et al.
Research Square|September 2, 2020
JAK-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-AnalysisLucas Walz, Avi J Cohen, Andre P Rebaza, et al.
BMC Infectious Diseases|January 12, 2021
JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19 patients: a systematic review and meta-analysisLucas Walz, Avi J Cohen, Andre P Rebaza, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Janus Kinase-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-AnalysisLucas Walz, Avi J Cohen, Andre P Rebaza, et al.
Ecancermedicalscience|November 21, 2022
Knowledge, attitudes and practices concerning breast cancer, cervical cancer and screening among healthcare professionals and students in Mogadishu, Somalia: a cross-sectional studyLucas Walz, Deqo Mohamed, Adam Haibah, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Pediatrics|December 23, 2022
Evidence Suggests a Decrease in the Incidence of Kernicterus in CaliforniaLucas Walz, Jordan C Brooks, Thomas Newman
Developmental Medicine and Child Neurology|April 10, 2023
Severe cerebral palsy survival is similar in California, USA and Victoria, AustraliaLucas Walz, Jordan C Brooks, David J Strauss, et al.
Multiple Sclerosis and Related Disorders|October 16, 2022
Life expectancy in multiple sclerosis by EDSS scoreLucas Walz, Jordan C Brooks, Robert M Shavelle, et al.
Breast Cancer Research and Treatment|August 26, 2020
Increasing accrual of minority patients in breast cancer clinical trialsAmelia A Trant, Lucas Walz, Whitney Allen, et al.
Plos One|November 23, 2021
Knowledge of and preparedness for COVID-19 among Somali healthcare professionals: A cross-sectional studyJude Alawa, Lucas Walz, Samir Al-Ali, et al.
BMJ Open|June 30, 2021
Knowledge and perceptions of COVID-19, prevalence of pre-existing conditions and access to essential resources in Somali IDP camps: a cross-sectional studyJude Alawa, Samir Al-Ali, Lucas Walz, et al.
Research Square|September 2, 2020
JAK-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-AnalysisLucas Walz, Avi J Cohen, Andre P Rebaza, et al.
BMC Infectious Diseases|January 12, 2021
JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19 patients: a systematic review and meta-analysisLucas Walz, Avi J Cohen, Andre P Rebaza, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Janus Kinase-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-AnalysisLucas Walz, Avi J Cohen, Andre P Rebaza, et al.
Ecancermedicalscience|November 21, 2022
Knowledge, attitudes and practices concerning breast cancer, cervical cancer and screening among healthcare professionals and students in Mogadishu, Somalia: a cross-sectional studyLucas Walz, Deqo Mohamed, Adam Haibah, et al.
Pageof 1